Clinical trial
Microcurrent for Fibromyalgia, a Double-Blinded, Placebo-Controlled Study
NCT04949100 is registered in ClinicalTrials.gov with Paul Crawford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microcurrent for Fibromyalgia, a Double-Blinded, Placebo-Controlled Study
- Lead sponsor
- Paul Crawford
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 25, 2021
- Completion date
- December 31, 2026
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.